Global epidemiology and burden of hepatitis C MICROBES AND INFECTION Kim, W. R. 2002; 4 (12): 1219-1225


Despite rapid progress in our knowledge of hepatitis C virology and pathogenesis, little is known about the current and future burden of this infection throughout the world. Prevalence and population-based studies have suggested that complications of the liver disease associated with chronic hepatitis C infection may potentially require substantial health care resources and generate very high costs for medical systems in the United States, Europe and worldwide. Careful understanding and assessment of hepatitis C health and economic burdens are likely to guide better programs for the management of infected individuals and the prevention of complications.

View details for Web of Science ID 000179410300004

View details for PubMedID 12467763